covaccine
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2008 (NCT00702221)
Timeline
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- covaccine
- covaccine ht
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01015703 | Phase 1 | Nov 1, 2009 | BTG, IQVIA |
| NCT00702221 | Phase 2 | Jun 1, 2008 | Acumen Pharmaceuticals, BTG, Encorium |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BTG | For profit | 2 | 2 | 2 | 2008 |
| Acumen Pharmaceuticals | For profit | 1 | 0 | 1 | 2008 |
| Encorium | For profit | 1 | 0 | 1 | 2008 |
| IQVIA | For profit | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1